Novo’s Weight-Loss Shot Wins Backing of FDA Advisory Panel (1)
Alert: HALISTER Source: BN (Bloomberg News)
Tickers ABT US (Abbott Laboratories) 3400398Z US (HHS Food & Drug Administration) NOVOB DC (Novo Nordisk A/S) OREX US (Orexigen Therapeutics Inc) ARNA US (Arena Pharmaceuticals Inc)
Topics Diabetes Obesity Cardiovascular Illnesses
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283